Identification of Biomarkers in Ischemic Stroke - Clinical Trial
Identification of Biomarkers in Ischemic Stroke - Clinical Trial
The objective of the study is to determine RNA blood biomarker based on 9 genes already identified in experimental studies, whose expression would be significantly increased in patient with ischemic stroke compared to controls.
This is a monocentric study. It's a case-control study with case being first-ever ischemic stroke and controls being healthy (stroke free) subject patients paired for age, sex and cardiovascular risk or hemorrhagic stroke paired for age and sex.
Patients are followed for one year. Blood samples will be taken at inclusion, 12h, 24h, 48h, 7d, 3m and 1y. Microvesicles samples will be taken at inclusion, 7d and 3M.
Inclusion Criteria:
For healthy controls :
Exclusion Criteria:
GROUP FOR ISCHEMIC STROKE :
- Patients with TIA and a negative cerebral CT or MRI
GROUP FOR HEMORRAGIC STROKE :
GROUP FOR HEALTHY CONTROLS :
- Contraindication MRI